Cancer Program Practice Profile Report

June 05, 2017


The Commission on Cancer (CoC), a program of the American College of Surgeons (ACoS), recognizes cancer care programs for their commitment to provide comprehensive, high-quality and multidisciplinary patient-centered care.

A Cancer Program Practice Profile Report (CP3R) has been newly released by the CoC and the ACoS from the National Cancer Database. 

This report offers local providers comparative information to assess adherence to and consideration of standard of care therapies for major cancers. Providence Little Company of Mary Medical Center Torrance (PLCMMCT) would like to share our outcomes to show how we compare to the local and national databases.

PLCMMCT’s performance rate on breast cancer was measured for a quality improvement measure with “image or palpation-guided needle biopsy to the primary site is performed to establish diagnosis of breast cancer” when benchmarked against local and national centers. 


In the most recently published data (shown above), our performance reveals a rate of 98.30% for 2014.  This high biopsy rate shows that the South Bay community is engaged with our cancer program and that patients are coming in for mammograms through our outreach efforts. 

The Women’s Imaging Center uses the most up-to-date technology in hopes of rendering an early diagnosis. Mammograms often mean early detection which can lead to a biopsy performed by our highly-skilled and specially-qualified radiologists.  Our pathologists, who are physicians that specialize in analyzing tissue specimens, then provide results for our biopsy specimens. Most of our positive findings are presented at Tumor Case Conference which provides our patients a multi-disciplinary approach to recommend treatment options.  Once a malignant diagnosis is established, our nurse navigators walk the patient and their loved ones through the treatment process, all the way to post-treatment where patients are provided with a Survivorship Care Plan. 

All cancer data is collected by the Cancer Registry which allows our cancer committee to monitor the quality improvement process for our cancer patients.  The data is submitted to the National Cancer Database where we can be compared for quality and outcomes.  This is truly a collaborative effort with our cancer care team.